Navigation Links
Dr. William S. Gruss, M.D., Says That Medical Research Shows You Can Reduce Your Risk of Cancer By Up To 77% and Reverse the Effects of Aging in A CARDIOLOGIST'S GUIDE TO ... ANTI-AGING, ANTIOXIDANTS & RESVERATROL
Date:4/8/2008

BOCA RATON, Fla., April 8, 2008 /PRNewswire/ -- It's common knowledge that Americans suffer under a crushing burden of chronic disease as they age. Heart disease is the leading cause of death for men AND women. Cancer is second. The statistics are staggering: one in two men and one in three women will develop some type of cancer. But how aware are we that scientific studies suggest that resveratrol and antioxidants could literally be a silver bullet in preventing several cancers and cardiovascular disease?

Dr. William S. Gruss, a well-respected Cardiologist and Board Certified Internist explains in plain language in A CARDIOLOGIST'S GUIDE TO ... ANTI- AGING, ANTIOXIDANTS & RESVERATROL how the latest medical research from prestigious doctors and universities (Dr. Gruss cites more than 200 published research papers!) proves that you can reduce your risk of cancer by up to 77% and your risk of dying from heart disease by 40%, PLUS reduce your risk of Alzheimer's, diabetes and other chronic diseases, and how you may even extend your lifespan.

In A CARDIOLOGIST'S GUIDE TO ... ANTI-AGING, ANTIOXIDANTS & RESVERATROL Dr. Gruss explains in easy-to-understand language the real causes of chronic illness and what you can do to avoid them. Dr. Gruss is concerned that although research scientists have proven the connection between inflammation, oxidation and chronic diseases, many doctors -- and their patients -- simply aren't getting the message.

One of the super supplements Dr. Gruss recommends that all Americans should begin taking immediately is resveratrol, a compound found in red wine, red wine extract, grapes and a few other plants. It has been in the news a lot lately, and in A CARDIOLOGIST'S GUIDE TO ... ANTI-AGING, ANTIOXIDANTS & RESVERATROL, Dr. Gruss thoroughly reviews the scientific literature and uncovers some astonishing research that has not yet hit the headlines.

In A CARDIOLOGIST'S GUIDE TO ... ANTI-AGING, ANTIOXIDANTS & RESVERATROL Dr. Gruss also reveals why medical experts are literally handing many of their patients a death sentence, simply because they refuse to stand up to the U.S. government and recommend vital health supplements. In fact, the publisher's attorneys begged Dr. Gruss to self-edit this book due to expected pressure from the medical establishment and the government!

A CARDIOLOGIST'S GUIDE TO ... ANTI-AGING, ANTIOXIDANTS & RESVERATROL, published by Renaissance Health Education, LLC, is for sale NOW in a hardcover edition on Amazon.com and direct from the publisher. MSRP: $29.95.


'/>"/>
SOURCE Renaissance Health Education, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Retired NYPD Lieutenants William E. Keegan, Jr., Owen McCaffery and John Moran and Tom Thees, a former COO in the financial industry, announce today the formation of H.E.A.R.T (Healing Emergency Aid Response Team) 911.
2. National Council of Negro Women (NCNW) Partners With Sherwin-Williams to Target Lead Risks in Neglected Housing
3. William Moore Appointed to IRIDEX Board of Directors
4. Exponent to Present at the Upcoming Sidoti & Company Investor Forum and William Blair Small-Cap Growth Stock Conference
5. AXA Equitable Life Insurance Co. Hires William McDermott to Lead Corporate Retirement Planning Business
6. AMICAS to Present at William Blair & Company Small Cap Growth Stock Conference
7. Matrixx Initiatives, Inc. to Present at the William Blair & Company Small-Cap Growth Stock Conference
8. iCAD to Present at William Blair & Company Small-Cap Growth Stock Conference
9. Presentation Time Correction: Keryx Biopharmaceuticals Presents at 12:00pm, ET Tomorrow (Oct. 3) at William Blair & Company Small-Cap Growth Stock Conference
10. VNUS Medical Technologies Presents at William Blair Small-Cap Growth Stock Conference
11. Prominent Cosmetic Dentist Dr. William Hoskyns Joins Leading Atlanta Practice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... As pharmaceutical companies ... to help with process innovation in drug formulation and manufacturing. CoreRx offers ... state-of-the-art analytical equipment in support of their development and manufacturing goals. , ...
(Date:4/25/2017)... Plains, NJ (PRWEB) , ... April 25, 2017 , ... Saad B. Chaudhary, MD is ... the treatment of acute or chronic problems, I focus on preventative care with all my ... If you have any questions, always feel free to contact my office and my trained ...
(Date:4/25/2017)... ... April 25, 2017 , ... Vetoquinol USA® , a ... UCII, part of the EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event ... the immunologic level. , The scientifically-developed Flexadin UCII supports the body’s normal repair ...
(Date:4/24/2017)... ... April 24, 2017 , ... Michael Vick announced his retirement ... quarterback position. The former overall number one pick in the 2001 NFL Draft, to ... holds the record for the most career rushing yards by a quarterback (6,109) and ...
(Date:4/24/2017)... ... April 24, 2017 , ... NEPC Director Kevin Welner ... Education Research Award. The award honors scholars exemplary in their capacity to communicate ... who has demonstrated the capacity to deepen the public’s understanding and appreciation of ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... Companion animal vaccines ... pets such as canine, avian and feline. ... such as Attenuated Live Vaccines, Conjugate Vaccines, Inactivated ... Recombinant Vaccines. Attenuated live vaccines are derived from ... have been weakend under laboratory conditions. Conjugate vaccines ...
(Date:4/18/2017)... -- Cardinal Health (NYSE: CAH ) today is ... share (EPS) guidance and providing a preliminary view on ... this morning,s announcement of the planned acquisition of Medtronic,s ... Cardinal Health now believes that fiscal 2017 ... bottom of its previous guidance range of $5.35 to ...
(Date:4/18/2017)... SAN DIEGO , April 18, 2017  Astute ... previewed a case series to be presented at the ... , which begins today and continues through April 22. ... and IGFBP-7 , used to assess risk for acute ... acute decompensated heart failure (ADHF). Elevated ...
Breaking Medicine Technology: